Today in this blog we will try to know Piramal Pharma Share Price Target 2025, 2026, 2027, To 2030 In this blog we are going to analyze the stock Piramal Pharma Ltd of the Pharmaceuticals sector. In this blog we will do all the research of the company for you like what does the company do? How can the performance of the company be for 5 years? Future status of the company? You will find information about all this research in this blog.
After reading this blog, you will also get to know about the technical analysis along with fundamentals about Piramal Pharma Ltd. From which you can find out whether you should invest in this company or not, so let’s try to know the company.
About Piramal Pharma Ltd
Piramal Pharma Limited is a leading Indian pharmaceutical company engaged in the development, manufacturing and sale of medicines. The company plays several key roles in the pharmaceutical industry and produces a wide variety of medicines and healthcare products.
Piramal Pharma Limited was founded in 1984. The company is headquartered in Mumbai, India.
| Company Name | Piramal Pharma Ltd |
| Market Cap | ₹ 79,214 Cr. |
| P/E | 70.2 |
| ROE (Return on equity) | 12.2 % |
| ROCE (Return on Capital Employed ) | 12.7 % |
| 52 Week High (09-Jan-2025) | ₹ 2,697.70 |
| 52 Week Low (04-Jun-2024) | ₹ 2,089.10 |
| DIV. YIELD | 0.27 % |
| Date of Listing | 18-Aug-2003 |
Piramal Pharma last 5 Year Performance
If we talk about the returns of Piramal Pharma Ltd (PPLPHARMA) share in the last few years, then the company has given 41.09% returns to its investors in the last 1 year (Jan 2024 – Jan 2025). And if we talk about Max Returns, then it has given 41.09% returns to its investors which is quite good.
| 3 Month Returns | 5.13% |
| 1 Year’s Returns | 63.78% |
| Max Returns | 41.09% |
| Sales growth 3 Years | 16.1 % |
| Sales growth 5 Years | – |
Read this also:- Saregama Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Piramal Pharma Share Price Target 2025-2030
| Year | Target 1 | Target 2 |
| 2025 | ₹260 | ₹300 |
| 2026 | ₹300 | ₹350 |
| 2027 | ₹350 | ₹400 |
| 2028 | ₹400 | ₹500 |
| 2029 | ₹450 | ₹600 |
| 2030 | ₹500 | ₹700 |
Piramal Pharma Share Price Target 2025
Talking about the Piramal Pharma Share Price Target 2025, our analysis has said that this stock can remain between ₹ 260 and ₹ 300 in 2025.
These targets are given after looking at the data of the past history of the stock. In this, fundamental analysis has been done along with technical analysis.
| Target 1 | Target 2 |
| ₹ 260 | ₹ 300 |
Piramal Pharma Share Price Target 2026
If the demand in this industry and the sales of this company see an increase, then as per our research the share price of Piramal Pharma may remain between ₹ 300 and ₹ 350 by 2026.
| Target 1 | Target 2 |
| ₹ 300 | ₹ 350 |
Read this also:- Dmart Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Piramal Pharma Share Price Target 2027
These share targets have been derived by looking at the company’s past performance. If the company’s performance remains good, then according to our analysts, the target for Piramal Pharma shares in 2027 can be between ₹ 350 and ₹ 400.
| Target 1 | Target 2 |
| ₹ 350 | ₹ 400 |
Piramal Pharma Share Price Target 2028
By analyzing the trend and stock of the last few years, it is known that if we talk about the target of Piramal Pharma share price in 2028, then it can be between ₹ 400 and ₹ 500.
| Target 1 | Target 2 |
| ₹ 400 | ₹ 500 |
Piramal Pharma Share Price Target 2029
Looking at the history of the last 5 years and the fundamental analysis of the stock, it seems that in the coming years i.e. if we talk about the target of Piramal Pharma Share in 2029, then ₹ 450 and ₹600 can be seen.
| Target 1 | Target 2 |
| ₹ 450 | ₹ 600 |
Piramal Pharma Share Price Target 2030
The price of Piramal Pharma stock can remain between ₹ 500 to ₹ 700 by 2030. This price can also go up or down, this price is told by analyzing the stock data of the last 5 years.
The price of the company’s stock depends on how the company performs in the coming time. You must take the help of your financial advisor before investing.
| Target 1 | Target 2 |
| ₹ 500 | ₹ 700 |
Piramal Pharma Promoters Holding
Friends, before investing in any company, it is very important to see the holding of the company’s promoters because from this we get an idea that if the promoters of the company have maintained their holding and are not selling it, then the company is performing well and can perform well.
It is said that it is not good if promoter’s holding is less in any company but it is said that if the holdings of FIIs and DIIs are increasing then it is good.
If we talk about the promoters’ holding in this company, it is 34.94%. You will see below who else has a stake in it.
| Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 34.78% | 35.02% | 34.94% |
| FIIs | 39.28% | 30.58% | 31.73% |
| DIIs | 4.98% | 12.12% | 13.80% |
| Public | 20.57% | 21.89% | 19.06% |
| Others | 0.39% | 0.37% | 0.45% |
Piramal Pharma Peer Companies
- Sun Pharma.Inds.
- Cipla
- Dr Reddy’s Labs
- Mankind Pharma
- Zydus Lifesci.
- Lupin
- Aurobindo Pharma
- Piramal Pharma
Conclusion
We hope that you have got all the information about Piramal Pharma Share Price Target 2025, 2026, 2027, To 2030 properly and how did you like our blog, please tell us by commenting and also tell us what are your thoughts about Piramal Pharma Ltd. Do share this article with your friends.
Frequently Asked Questions FAQ’S
How much debt does Piramal Pharma have?
As of today when we are posting this blog, Piramal Pharma Ltd has a debt of ₹ 4,786 Cr.
What does Piramal Pharma Ltd do?
Piramal Pharma Limited is a leading Indian pharmaceutical company engaged in the development, manufacturing and sale of medicines. The company plays several key roles in the pharmaceutical industry and produces a wide variety of medicines and healthcare products.
Read this also:- PTC Industries Share Price Target 2025, 2026, 2027, To 2030 – Stock Era
Disclaimer : The information presented in this article is for educational and informational purposes only. We do not recommend buying or selling stocks. These predictions are based on our research and technical data, any uncertainty in the market may affect the stock price, so investors should do their own research before making investment decisions. We will not be responsible for any loss or damage caused by the use of this article.